TherapeuticsMD, Inc. Contracts & Agreements

Master Service Agreement, dated August 15, 2023, between TherapeuticsMD, Inc. and JZ Advisory Group (Filed With SEC on November 14, 2023)

Description of Securities of the Company (Filed With SEC on April 7, 2023)

Amendment No. 1 to the License Agreement between TherapeuticsMD, Inc. and Mayne Pharma LLC, dated as of December 30, 2022 (Filed With SEC on April 7, 2023)

Amendment No. 1 to the Transaction Agreement between TherapeuticsMD, Inc. and Mayne Pharma LLC, dated as of December 30, 2022 (Filed With SEC on April 7, 2023)

Amended and Restated Employment Agreement, dated as of December 18, 2018, by and between TherapeuticsMD, Inc. and Marlan Walker (Filed With SEC on April 7, 2023)

Amendment, effective October 15, 2021, to the Employment Agreement, dated as of December 18, 2018, by and between TherapeuticsMD, Inc. and Marlan Walker (Filed With SEC on April 7, 2023)

Amendment, dated February 21, 2023, to the Employment Agreement, dated as of December 18, 2018, as extended effective October 15, 2021, by and between TherapeuticsMD, Inc. and... (Filed With SEC on February 27, 2023)

General Consulting and Services Agreement by and between TherapeuticsMD, Inc. and MCD Consulting Management Services, LLC, dated February 21, 2023 (Filed With SEC on February 27, 2023)

License Agreement by and between TherapeuticsMD, Inc. and Mayne Pharma LLC, dated December 4, 2022 (Filed With SEC on December 5, 2022)

Transaction Agreement by and between TherapeuticsMD, Inc. and Mayne Pharma LLC, dated December 4, 2022 (Filed With SEC on December 5, 2022)

Amendment No. 12 to the Financing Agreement, dated July 13, 2022, by and among TherapeuticsMD, Inc. as the Borrower, vitaMedMD, LLC, BocaGreenMD, Inc. and vitaCare Prescription... (Filed With SEC on November 14, 2022)

Amendment No. 13 to the Financing Agreement, dated July 24, 2022, by and among TherapeuticsMD, Inc. as the Borrower, vitaMedMD, LLC, BocaGreenMD, Inc. and vitaCare Prescription... (Filed With SEC on November 14, 2022)

Amendment No. 14 to the Financing Agreement, dated July 27, 2022, by and among TherapeuticsMD, Inc. as the Borrower, vitaMedMD, LLC, BocaGreenMD, Inc. and vitaCare Prescription... (Filed With SEC on November 14, 2022)

Amendment No. 15 to the Financing Agreement, dated July 28, 2022, by and among TherapeuticsMD, Inc. as the Borrower, vitaMedMD, LLC, BocaGreenMD, Inc. and vitaCare Prescription... (Filed With SEC on November 14, 2022)

Subscription Agreement between TherapeuticsMD, Inc. and Rubric Capital Management LP, dated October 28, 2022 (Filed With SEC on October 31, 2022)

Subscription Agreement by and among TherapeuticsMD, Inc., Sixth Street Specialty Lending, Inc., TOP IV Talents, LLC and TAO Talents, LLC, dated October 28, 2022 (Filed With SEC on October 31, 2022)

Subscription Agreement between TherapeuticsMD, Inc. and Rubric Capital Management LP, dated September 30, 2022 (Filed With SEC on October 3, 2022)

Subscription Agreement by and among TherapeuticsMD, Inc., Sixth Street Specialty Lending, Inc., TOP IV Talents, LLC and TAO Talents, LLC, dated September 30, 2022 (Filed With SEC on October 3, 2022)

Subscription Agreement between TherapeuticsMD, Inc. and Rubric Capital Management LP, dated July 29, 2022 (Filed With SEC on August 1, 2022)

Subscription Agreement by and among TherapeuticsMD, Inc., Sixth Street Specialty Lending, Inc., TOP IV Talents, LLC and TOA Talents, LLC, dated July 29, 2022 (Filed With SEC on August 1, 2022)

Amendment No. 16 to Financing Agreement, dated July 29, 2022, by and among TherapeuticsMD, Inc., VitaMedMD, LLC, BocagreenMD, Inc., Sixth Street Specialty Lending, Inc., Top IV... (Filed With SEC on August 1, 2022)

Agreement and Plan of Merger, dated as of May 27, 2022, among TherapeuticsMD, Inc., Athene Parent, Inc. and Athene Merger Sub, Inc (Filed With SEC on May 31, 2022)

Amendment No. 10 to Financing Agreement, dated May 27, 2022, by and among TherapeuticsMD, Inc., VitaMedMD, LLC, BocagreenMD, Inc., Sixth Street Specialty Lending, Inc., Top IV... (Filed With SEC on May 31, 2022)

2022 Executive Retention and Performance Bonus Plan. (ERB-Plan) (Filed With SEC on March 23, 2022)

Stock Purchase Agreement, dated as of March 6, 2022, by and between TherapeuticsMD, Inc. and GoodRx, Inc (Filed With SEC on March 10, 2022)

Amendment No. 9 to Financing Agreement, dated March 9, 2022, by and among TherapeuticsMD, Inc., VitaMedMD, LLC, BocagreenMD, Inc., VitaCare Prescription Services, Inc., Sixth... (Filed With SEC on March 10, 2022)

Amendment to Employment Agreement between TherapeuticsMD, Inc. and James C. DArecca, dated October 15, 2021 (Filed With SEC on November 12, 2021)

Executive Employment Agreement, dated as of August 3, 2021, by and between TherapeuticsMD, Inc. and Hugh ODowd (Filed With SEC on August 9, 2021)

Amendment, dated April 8, 2021, to the Amended and Restated Employment Agreement, dated as of November 24, 2020, by and between TherapeuticsMD, Inc. and John C.K. Milligan, IV (Filed With SEC on April 12, 2021)

Second Amendment to Company Warrant issued by the Company to the Subscribers party to that certain Subscription Agreement, dated as of August 5, 2020 (Filed With SEC on March 4, 2021)

Warrant issued by the Company to Robert Finizio (Filed With SEC on March 4, 2021)

Amendment to Warrant issued by the Company to Robert Finizio (Filed With SEC on March 4, 2021)

Warrant issued by the Company to John C.K. Milligan, IV (Filed With SEC on March 4, 2021)

Amendment to Warrant issued by the Company to John C.K. Milligan, IV (Filed With SEC on March 4, 2021)

Amendment No. 7 to the Financing Agreement, by and among TherapeuticsMD, Inc., VitaMedMD, LLC, BocagreenMD, Inc., VitaCare Prescription Services, Inc., Sixth Street Specialty... (Filed With SEC on March 4, 2021)

Amendment No. 8 to the Financing Agreement, by and among TherapeuticsMD, Inc., VitaMedMD, LLC, BocagreenMD, Inc., VitaCare Prescription Services, Inc., Sixth Street Specialty... (Filed With SEC on March 4, 2021)

Employment Agreement between the Company and Edward J. Borkowski (Filed With SEC on March 4, 2021)

Amendment to Employment Agreement between the Company and Edward J. Borkowski (Filed With SEC on March 4, 2021)

Underwriting Agreement, dated February 11, 2021, by and between the Company and Cantor Fitzgerald & Co., as representative of the several underwriters named therein (Filed With SEC on February 16, 2021)

Controlled Equity OfferingSM Sales Agreement, dated November 27, 2020, by and between TherapeuticsMD, Inc. and Cantor Fitzgerald & Co (Filed With SEC on November 27, 2020)

Amended and Restated Employment Agreement, dated as of November 24, 2020, by and between TherapeuticsMD, Inc. and Robert Finizio (Filed With SEC on November 27, 2020)

Amended and Restated Employment Agreement, dated as of November 24, 2020, by and between TherapeuticsMD, Inc. and John C.K. Milligan, IV (Filed With SEC on November 27, 2020)

Amended and Restated Employment Agreement, dated as of November 24, 2020, by and between TherapeuticsMD, Inc. and Michael Donegan (Filed With SEC on November 27, 2020)

Underwriting Agreement, dated November 10, 2020, by and between the Company and Cantor Fitzgerald & Co., as representative of the several underwriters named therein (Filed With SEC on November 13, 2020)

Amendment to Form of Warrant to Purchase Common Stock issued by TherapeuticsMD, Inc. to the Subscribers party to that certain Subscription Agreement, dated as of August 5, 2020 (Filed With SEC on November 9, 2020)

Form of Indemnification Agreement between TherapeuticsMD, Inc. and each of its executive officers and directors (Filed With SEC on November 9, 2020)

Amendment No. 6 to Financing Agreement, by and among TherapeuticsMD, Inc., VitaMedMD, LLC, BocagreenMD, Inc., vitaCare Prescription Services, Inc., Sixth Street Specialty Lending,... (Filed With SEC on November 9, 2020)

Amendment No. 1 to the Commercial Supply Agreement, between TherapeuticsMD, Inc. and Catalent Pharma Solutions, LLC (Filed With SEC on November 9, 2020)

Amendment No. 2 to the Commercial Supply Agreement, between TherapeuticsMD, Inc. and Catalent Pharma Solutions, LLC (Filed With SEC on November 9, 2020)

Amendment No. 2 to the Softgel Commercial Supply Agreement, between TherapeuticsMD, Inc. and Catalent Pharma Solutions, LLC (Filed With SEC on November 9, 2020)

Form of Warrant to Purchase Common Stock issued by TherapeuticsMD, Inc. to the Subscribers party to that certain Subscription Agreement, dated as of August 5, 2020 (Filed With SEC on August 7, 2020)

Amendment No. 2 to Financing Agreement, by and among TherapeuticsMD, Inc., VitaMedMD, LLC, BocagreenMD, Inc., VitaCare Prescription Services, Inc., TPG Specialty Lending, Inc. and... (Filed With SEC on August 7, 2020)

Amendment No. 3 to Financing Agreement, by and among TherapeuticsMD, Inc., VitaMedMD, LLC, BocagreenMD, Inc., VitaCare Prescription Services, Inc., TPG Specialty Lending, Inc.,... (Filed With SEC on August 7, 2020)

Amendment No. 4 to Financing Agreement, by and among TherapeuticsMD, Inc., VitaMedMD, LLC, BocagreenMD, Inc., VitaCare Prescription Services, Inc., TPG Specialty Lending, Inc.,... (Filed With SEC on August 7, 2020)

Amendment No. 5 to Financing Agreement, by and among TherapeuticsMD, Inc., VitaMedMD, LLC, BocagreenMD, Inc., VitaCare Prescription Services, Inc., TPG Specialty Lending, Inc.,... (Filed With SEC on August 7, 2020)

Subscription Agreement, by and among TherapeuticsMD, Inc. and the Subscribers identified on the Schedule of Subscribers attached thereto (Filed With SEC on August 7, 2020)

Employment Agreement, by and between TherapeuticsMD, Inc. and James C. DArecca (Filed With SEC on August 7, 2020)

Description of Securities of the Company (Filed With SEC on February 24, 2020)

Amendment No. 1 to the Financing Agreement, by and among TherapeuticsMD, Inc., VitaMedMD, LLC, BocagreenMD, Inc., VitaCare Prescription Services, Inc., TPG Specialty Lending,... (Filed With SEC on February 24, 2020)

Commercial Supply Agreement by and between TherapeuticsMD, Inc. and QPharma AB (Filed With SEC on November 8, 2019)

Lease by and between 951 Yamato Acquisition Company, LLC and TherapeuticsMD, Inc (Filed With SEC on November 8, 2019)

Underwriting Agreement, dated October 24, 2019, by and between the Company and J.P. Morgan Securities LLC, as representative of the several underwriters named therein (Filed With SEC on October 29, 2019)

Softgel Commercial Supply Agreement, by and between TherapeuticsMD, Inc. and Catalent Pharma Solutions, LLC (Filed With SEC on February 27, 2019)

Population Council License Agreement, by and between TherapeuticsMD, Inc. and The Population Council, Inc (Filed With SEC on November 8, 2018)

Amendment No. 1 to the Credit and Security Agreement, by and among TherapeuticsMD, Inc., as borrower, its subsidiaries party thereto from time to time, each as a borrower, MidCap... (Filed With SEC on November 8, 2018)

Underwriting Agreement, dated August 1, 2018, by and between the Company and Goldman Sachs & Co. LLC, as representative of the several underwriters named therein (Filed With SEC on August 3, 2018)

Softgel Commercial Supply Agreement, by and between TherapeuticsMD, Inc. and Catalent Pharma Solutions, LLC (Filed With SEC on July 30, 2018)

Underwriting Agreement, dated September 25, 2017, by and between the Company and J.P. Morgan Securities LLC (Filed With SEC on September 28, 2017)

Third Amendment to Lease between the Company and 6800 Broken Sound, LLC (Filed With SEC on November 4, 2016)

Second Amendment to Lease between the Company and 6800 Broken Sound, LLC (Filed With SEC on May 5, 2016)

Consulting Agreement between the Company and Sancilio and Company, Inc (Filed With SEC on February 26, 2016)

TherapeuticsMD, Inc. Common Stock Underwriting Agreement (Filed With SEC on January 12, 2016)

EMPLOYMENTAGREEMENT (Filed With SEC on December 22, 2015)

THERAPEUTICSMD, INC. $30,000,001.20 COMMON STOCK UNDERWRITING AGREEMENT (Filed With SEC on July 15, 2015)

THERAPEUTICSMD, INC. $54,999,996.30 COMMON STOCK UNDERWRITING AGREEMENT (Filed With SEC on February 17, 2015)

TherapeuticsMD, Inc. Common Stock Underwriting Agreement (Filed With SEC on August 4, 2014)

9,000,000 Shares TherapeuticsMD, Inc. UNDERWRITING AGREEMENT (Filed With SEC on March 21, 2014)

13,750,000 Shares TherapeuticsMD, Inc. UNDERWRITING AGREEMENT (Filed With SEC on September 25, 2013)

Amended and Restated 2012 Stock Incentive Plan (Filed With SEC on August 22, 2013)

Lease between the Company and 6800 Broken Sound LLC (Filed With SEC on August 7, 2013)

AGREEMENT TO FORFEIT NON-QUALIFIED STOCK OPTIONS (Filed With SEC on May 10, 2013)

Consulting Agreement (Filed With SEC on May 10, 2013)

29,411,765 Shares TherapeuticsMD, Inc. UNDERWRITING AGREEMENT (Filed With SEC on March 15, 2013)

TherapeuticsMD,Inc. (the “Company”) AUDITCOMMITTEE CHARTER (Filed With SEC on March 12, 2013)

TherapeuticsMD, Inc. (the “Company”) COMPENSATION COMMITTEE CHARTER (Filed With SEC on March 12, 2013)

TherapeuticsMD, Inc. (the “Company”) NOMINATING AND CORPORATE GOVERNANCE COMMITTEE CHARTER (Filed With SEC on March 12, 2013)

Multiple Advance Revolving Credit Note, issued to Plato & Associates, LLC (Filed With SEC on February 6, 2013)

Common Stock Purchase Warrant, issued to Plato & Associates, LLC (Filed With SEC on February 6, 2013)

Secured Promissory Note between the Company and Johnson and Plato, form of (Filed With SEC on November 13, 2012)

Securities Purchase Agreement, form of (Filed With SEC on October 2, 2012)

Master Services Agreement with Sancilio and Company, Inc (Filed With SEC on August 9, 2012)

Consulting Agreement with Sancilio and Company, Inc (Filed With SEC on August 9, 2012)

Note Purchase Agreement (Filed With SEC on June 21, 2012)

Secured Promissory Note, form of (Filed With SEC on June 21, 2012)

Security Agreement (Filed With SEC on June 21, 2012)

Common Stock Purchase Warrant, form of (Filed With SEC on June 21, 2012)

THERAPEUTICSMD, INC. CHARTER OF AUDIT COMMITTEE (Filed With SEC on March 2, 2012)

THERAPEUTICSMD, INC. CHARTER OF COMPENSATION COMMITTEE (Filed With SEC on March 2, 2012)

THERAPEUTICSMD, INC. CHARTER OF CORPORATE GOVERNANCE COMMITTEE (Filed With SEC on March 2, 2012)

Note Purchase Agreement (Filed With SEC on February 24, 2012)

Secured Promissory Note, form of (Filed With SEC on February 24, 2012)

Security Agreement (Filed With SEC on February 24, 2012)

Common Stock Purchase Warrant, form of (Filed With SEC on February 24, 2012)

Lang Financing Agreement (Filed With SEC on February 2, 2012)

Lang Financing Agreement (Filed With SEC on December 9, 2011)

Promissory Note, form of (Filed With SEC on November 23, 2011)

Senior Secured Promissory Note, form of (Filed With SEC on November 22, 2011)

Security Agreement, form of (Filed With SEC on November 22, 2011)

Convertible Promissory Note, form of (Filed With SEC on November 22, 2011)

Software License Agreement with Pernix Therapeutics, LLC (Filed With SEC on November 7, 2011)

Debt Conversion Agreement with Energy Capital, LLC (Filed With SEC on October 24, 2011)

Debt Conversion Agreement with First Conquest Investment Group, LLC (Filed With SEC on October 24, 2011)

Convertible Promissory Note with Energy Capital, LLC (Filed With SEC on October 24, 2011)

Convertible Promissory Note with First Conquest Investment Group, LLC (Filed With SEC on October 24, 2011)

Consulting Agreement with Lang Naturals, Inc (Filed With SEC on October 24, 2011)

Warrant to Lang Naturals, Inc (Filed With SEC on October 24, 2011)

Lock-Up Agreement with Lang Naturals, Inc (Filed With SEC on October 24, 2011)

Non-qualified Stock Option, form of (Filed With SEC on October 11, 2011)

Common Stock Purchase Warrant, form of (Filed With SEC on October 11, 2011)

Stock Purchase Agreement between the Company and Pernix Therapeutics, LLC (Filed With SEC on September 14, 2011)

Lock-Up Agreement between the Company and Pernix Therapeutics, LLC (Filed With SEC on September 14, 2011)

AGREEMENT AND PLAN OF MERGER (Filed With SEC on July 21, 2011)

Promissory Note to Philip M. Cohen for $210,000 (Filed With SEC on May 19, 2011)

Convertible Promissory Note to First Conquest Investment Group, L.L.C. for $105,000 (Filed With SEC on May 19, 2011)

Convertible Promissory Note to Energy Capital, LLC for $105,000 (Filed With SEC on May 19, 2011)

Sales Representation Agreement with Mann Equity, LLC (Filed With SEC on May 19, 2011)

Consulting Agreement with Back Office Consultants, Inc (Filed With SEC on February 18, 2011)

Agreement, Acknowledgment and Consent between the Company and Seatac (Filed With SEC on February 18, 2011)

Joint Direction to Release Pledged Interests from Escrow (Filed With SEC on February 18, 2011)

Trademark Assignment and Agreement (Filed With SEC on February 18, 2011)

Exclusive Licensing, Distribution and Advertising Sales Agreement (Filed With SEC on February 18, 2011)

Resignation of Robert Cambridge (Filed With SEC on February 18, 2011)

AMHN, INC. $487,532 SECURED PROMISSORY NOTE DUE ON DEMAND NOTE PURCHASE AGREEMENT by and between AMHN, INC. and SEATAC DIGITAL RESOURCES, INC. DATED DECEMBER 16, 2010 (Filed With SEC on December 22, 2010)

AMHN, INC. SECURED PROMISSORY NOTE Due on Demand (Filed With SEC on December 22, 2010)

STOCK PLEDGE AND ESCROW AGREEMENT (Filed With SEC on December 22, 2010)

SECURITY AGREEMENT (Filed With SEC on December 22, 2010)

GUARANTOR SECURITY AGREEMENT (Filed With SEC on December 22, 2010)

GUARANTY AGREEMENT (Filed With SEC on December 22, 2010)

CONFIRMATORY ASSIGNMENT OF SECURITY INTEREST IN UNITED STATES PATENTS,TRADEMARKS, AND COPYRIGHTS (Filed With SEC on December 22, 2010)

Seatac Digital Resources, Inc. (Filed With SEC on August 3, 2010)

AGREEMENT, ACKNOWLEDGMENT AND CONSENT (Filed With SEC on August 3, 2010)

JOINT DIRECTION TO RELEASE PLEDGED INTERESTS FROM ESCROW (Filed With SEC on August 3, 2010)

TRADEMARK ASSIGNMENT AND AGREEMENT (Filed With SEC on August 3, 2010)

AGREEMENT AND PLAN OF REORGANIZATION AMONG AMHN,INC., SHN ACQUISITION CORP., SPECTRUM HEALTH NETWORK, INC., AND THE SOLESHAREHOLDER OF SPECTRUM HEALTH NETWORK, INC. June 11, 2010... (Filed With SEC on June 14, 2010)

AMHN, INC. 100 North First Street, Suite 104 Burbank, CA 91502 ###-###-#### (Filed With SEC on June 4, 2010)

AMHN, INC. $800,000 SECURED PROMISSORY NOTE DUE JUNE 30, 2010 NOTE PURCHASE AGREEMENT By and Between AMHN, INC. (Filed With SEC on April 7, 2010)

AMHN, INC. SECURED PROMISSORY NOTE (Filed With SEC on April 7, 2010)

STOCK PLEDGE AND ESCROW AGREEMENT (Filed With SEC on April 7, 2010)

SECURITY AGREEMENT (Filed With SEC on April 7, 2010)

GUARANTOR SECURITY AGREEMENT (Filed With SEC on April 7, 2010)

GUARANTY AGREEMENT (Filed With SEC on April 7, 2010)

Promissory Note (Filed With SEC on March 17, 2010)

Seatac Digital Resources, Inc. (Filed With SEC on March 17, 2010)

Promissory Note (Filed With SEC on November 16, 2009)

Global Arena Capital Corp. 708 Third Avenue NEW YORK, NY 10017 (Filed With SEC on November 16, 2009)

Promissory Note (Filed With SEC on November 16, 2009)

Seatac Digital Resources, Inc. (Filed With SEC on November 16, 2009)

Promissory Note (Filed With SEC on November 16, 2009)

Promissory Note (Filed With SEC on July 30, 2009)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 30, 2009)

Seatac Digital Resources, Inc. (Filed With SEC on July 30, 2009)

Promissory Note (Filed With SEC on July 30, 2009)

AGREEMENTAND PLAN OF REORGANIZATION AMONG CROFFENTERPRISES, INC., AMHNACQUISITION CORP., AMERICASMINORITY HEALTH NETWORK, INC. AND THEMAJOR SHAREHOLDERS Listedon Schedule A Hereto... (Filed With SEC on July 10, 2009)

Category

Industry

Companies

Contracts

TherapeuticsMD, Inc. Contracts & Agreements